Peony root extract upregulates transthyretin and phosphoglycerate mutase in mouse cobalt focus seizure

Biochemical and Biophysical Research Communications

Volumn 371, Issue 3, 2008, Pages 375-379

  Kajiwara, Kagemasa ^a   Sunaga, Katsuyoshi ^b   Tsuda, Tadashi ^b   Sugaya, Aiko ^c   Sugaya, Eiichi ^c   Kimura, Minoru ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c Aieido Clinic for Kampo Medicine   (Japan)

Author keywords

Cobalt focus seizure model; Neurogranin RC3; Peony root; Phosphoglycerate mutase; Transthyretin

Indexed keywords

COBALT; GLYCOLYTIC ENZYME; NEUROGRANIN; PAEONIA RADIX; PHOSPHOGLYCERATE MUTASE; PREALBUMIN; RETINOID; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN LEVEL; COBALT FOCUS SEIZURE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; MASS SPECTROMETRY; MOUSE; NERVE CELL NECROSIS; NEUROCHEMISTRY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; TRANSCRIPTION INITIATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; ANTICONVULSANTS; CEREBRUM; COBALT; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MICE; MICE, INBRED C57BL; NEUROGRANIN; PAEONIA; PHOSPHOGLYCERATE MUTASE; PLANT EXTRACTS; PLANT ROOTS; PREALBUMIN; PROTEOMICS; SEIZURES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYROID HORMONES; UP-REGULATION;

PAEONIA;

EID: 43549113100     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.094     Document Type: Article

References (26)

1. Sugaya E., Ishige A., Sediguchi K., Yuzurihara M., Iizuka S., Sugimoto A., and Hosoya E. Damage of hippocampal neurons caused by cobalt focus in the cerebral cortex of rats. Brain Res. 459 (1988) 196-199
2. Tsuda T., Sugaya A., Ohguchi H., Kishida N., and Sugaya E. Protective effects of peony root extract and its components on neuron damage in the hippocampus induced by the cobalt focus epilepsy model. Exp. Neurol. 146 (1997) 518-525
3. Sugaya A., Suzuki T., Sugaya E., Yuyama N., Yasuda K., and Tsuda T. Inhibitory effect of peony root extract on pentylenetetrazol-induced EEG power spectrum changes and extracellular calcium concentration changes in rat cerebral cortex. J. Ethnopharmacol. 33 (1991) 159-167
4. Sunaga K., Sugaya E., Kajiwara K., Tsuda T., Sugaya A., and Kimura M. Molecular mechanism of preventive effect of peony root extract on neuron damage. J. Herb. Pharmacother. 4 (2004) 9-20
5. Liu J., Jin D.Z., Xiao L., and Zhu X.Z. Paeoniflorin attenuates chronic cerebral hypoperfusion-induced learning dysfunction and brain damage in rats. Brain Res. 1089 (2006) 162-170
6. Palha J.A., and Goodman A.B. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res. Brain Res. Rev. 51 (2006) 61-71
7. Zhang J., Yu L., Fu Q., Gao J., Xie Y., Chen J., Zhang P., Liu Q., and Zhao S. Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. Gene 264 (2001) 273-279
8. Morgan J.I., Cohen D.R., Hempstead J.L., and Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237 (1987) 192-197
9. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
10. Feart C., Mingaud F., Enderlin V., Husson M., Alfos S., Higueret P., and Pallet V. Differential effect of retinoic acid and triiodothyronine on the age-related hypo-expression of neurogranin in rat. Neurobiol. Aging 26 (2005) 729-738
11. Enderlin V., Vallortigara J., Alfos S., Feart C., Pallet V., and Higueret P. Retinoic acid reverses the PTU related decrease in neurogranin level in mice brain. J. Physiol. Biochem. 60 (2004) 191-198
12. Husson M., Enderlin V., Alfos S., Boucheron C., Pallet V., and Higueret P. Expression of neurogranin and neuromodulin is affected in the striatum of vitamin A-deprived rats. Brain Res. Mol. Brain Res. 123 (2004) 7-17
13. Husson M., Enderlin V., Alfos S., Feart C., Higueret P., and Pallet V. Triiodothyronine administration reverses vitamin A deficiency-related hypo-expression of retinoic acid and triiodothyronine nuclear receptors and of neurogranin in rat brain. Br. J. Nutr. 90 (2003) 191-198
14. Heuer H., and Mason C.A. Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor alpha1. J. Neurosci. 23 (2003) 10604-10612
15. Morte B., Manzano J., Scanlan T., Vennstrom B., and Bernal J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc. Natl. Acad. Sci. USA 99 (2002) 3985-3989
16. Lane M.A., and Bailey S.J. Role of retinoid signalling in the adult brain. Prog. Neurobiol. 75 (2005) 275-293
17. McCaffery P., Zhang J., and Crandall J.E. Retinoic acid signaling and function in the adult hippocampus. J. Neurobiol. 66 (2006) 780-791
18. Crandall J., Sakai Y., Zhang J., Koul O., Mineur Y., Crusio W.E., and McCaffery P. 13-Cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc. Natl. Acad. Sci. USA 101 (2004) 5111-5116
19. Fleming C.E., Sraiva M.J., and Sousa M.M. Transthyretin enhances nerve regeneration. J. Neurochem. 103 (2007) 831-839
20. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65 (2005) 177-185
21. Boyd-Kimball D., Sultana R., Poon H.F., Lynn B.C., Casamenti F., Pepeu G., Klein J.B., and Butterfield D.A. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 132 (2005) 313-324
22. Castegna A., Thongboonkerd V., Klein J., Hynn B.C., Wang Y.-L., Osaka H., Wada K., and Butterfield D.A. Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. J. Neurochem. 88 (2004) 1540-1546
23. Biroccio A., Del Boccio P., Panella M., Bernardini S., Di Ilio C., Gambi D., Stanzione P., Sacchetta P., Bernardi G., Martorana A., Federici G., Stefani A., and Urbani A. Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics 6 (2006) 2305-2313
24. Castano E.M., Roher A.E., Esh C.L., Kokjohn T.A., and Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects. Neurol. Res. 28 (2006) 155-163
25. Huang J.T.-J., Leweke F.M., Oxley D., Wang L., Harris N., Koethe D., Gerth C.W., Nolden B.M., Gross S., Schreiber D., Reed B., and Bahn S. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med. 3 (2006) 2145-2158
26. Sullivan G.M., Mann J.J., Oquendo M.A., Lo E.S., Cooper T.B., and Gorman J.M. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biol. Psychiatry 60 (2006) 500-506